RHYTHM AI’s management team consists of a number of experts within their field. Each have developed a respected reputation in their area of expertise.
Simon HubbertFounder & Chief Executive Officer
Simon has over 25 years international experience in the medical device industry and has held a number of CEO, senior commercial and general management positions in global medtech companies including Johnson & Johnson, Medtronic, Lombard Medical, Oxford Medtech Consulting and LMA International.
Ian ArdillChief Financial Officer
An experienced finance executive with twelve years as CFO/Finance Director/Company Secretary in publicly listed pharmaceutical and medical technology companies. Over 20 years’ experience in senior financial positions in successful manufacturing and service businesses, with the majority of that time in medical devices and pharmaceuticals.
Linda D’Abate Vice President, Regulatory & Clinical Affairs & Quality
Linda has more than 25 years of experience in the medical device industry, with significant contributions and accomplishments in medical device approvals. She has previously worked as Vice President of Regulatory and Clinical Affairs and Quality, for public and private companies including, Reverse Medical, The Weinberg Group, Rubicon Medical, TherOx, Inc., Micro Therapeutics, Inc., Lombard Medical and Pilot Cardiovascular Systems, Inc.
Shohreh HonarbakhshFounder and Chief Scientific Officer
Shohreh has a special interest in the mechanisms sustaining AF and has published extensively in this area. As part of a BHF project grant she has completed a PhD on the identification of driver regions in persistent AF and their relationship to structural remodelling. She attained the Heart Rhythm Society Young Investigator Award 2018 in Boston and the Heart Rhythm Congress Young Investigator Award 2017 in London for her work on identifying and characterising localised drivers in AF.
Xinwei ShiChief Technology Officer
Xinwei is an expert in developing algorithms and software for biomedical applications including protein folding and electrophysiology mapping. He has a strong passion for innovating technologies to map Atrial Fibrillation and improve the outcome of catheter ablation. Previously, he led the research team at Acutus Medical to develop a noncontact mapping system.
Discover STAR Mapping™
STAR Mapping™ has been tested in patients undergoing catheter ablation. Clinical trials validated that STAR Mapping™ correctly identified abnormal rhythm mechanisms, reduced time spent on ablation and is able to analyse more data than a human observer.